Bringing us closer to the goal of a future without disease
Bringing us closer to the goal of a future without disease
Dr Thorsten Giesecke, general manager, commercial business at Janssen Sciences Ireland UC and Irish Pharmaceutical Industry Association (IPHA) strategy board member, outlined in The Irish Times how clinical trials play a critical role in addressing the unmet need in the treatment of the blood cancer, multiple myeloma, and bring us closer to the goal of a future without disease.
You can read the article HERE
CP-395854 | August 2023